Keenova Therapeutics
GOLDENTREE ASSET MANAGEMENT LP (10% owner) bought 295,716 Keenova Therapeutics plc at $89.25, worth $26.4M
Form 4 on Keenova Therapeutics, filed with the SEC on Nov 9, 2026, 5:30 pm ET. Source: the filing on SEC EDGAR.
- Form
- 4
- Filed
- Importance
- Major
- Accession
- 0001493152-26-050818
- 145,716 ordinary shares acquired on Nov 5, 2026
- 150,000 ordinary shares acquired on Nov 6, 2026
- Total owned shares: 8,875,543
Written from the Form 4 on EDGAR. AI can make mistakes. Check the filing.
